El trasplante alogénico de progenitores hematopoyéticos en la era de las nuevas terapias en la leucemia linfoblástica aguda

Barba, Pere; Elorza, Izaskun.
Med. clín (Ed. impr.) ; 153(1): 28-34, jul. 2019. tab
Artículo en Español | IBECS (España) | ID: ibc-183354

Documentos relacionados

  1. Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel.
  2. Modulation of CD19 surface expression in B cell acute lymphoblastic leukemia.
  3. RaScALL: Rapid (Ra) screening (Sc) of RNA-seq data for prognostically significant genomic alterations in acute lymphoblastic leukaemia (ALL).
  4. Management of ALL in adults: 2024 ELN recommendations from a European expert panel.
  5. Raman classification of selected subtypes of acute lymphoblastic leukemia (ALL).
  6. The Philadelphia Chromosome, from Negative to Positive: A Case Report of Relapsed Acute Lymphoblastic Leukemia Following Allogeneic Stem Cell Transplantation.
  7. Characterisation of children and adolescents with acute lymphoblastic leukaemia who presented without peripheral blood blasts at diagnosis.
  8. Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation.
  9. Infant Acute Lymphoblastic Leukemia-New Therapeutic Opportunities.
  10. Genetic Profiling in Children With Acute Lymphoblastic Leukemia Referred for Allogeneic Hematopoietic Stem Cell Transplantation.